CT-guided argon-helium cryoablation for abdominal metastatic tumors:a preliminary report

HUANGHao-zhe,XULi-chao,LIGuo-dong,HEXin-hong,WANGYing,LIWen-tao
2014-01-01
Abstract:Objective To investigate the short-term clinical benefit of cryoablation for abdominal metastatic tumors under CT guidance. Methods A total of 9 patients with confirmed abdominal metastatic tumors received argon-helium cryoablation under CT guidance. Results All patients had successful cryotherapy with the average ice-ball coverage rate of (95.0± 4.8)%. The mean cryoablation time and rewarming time was (22.4±7.6) min and (11.2±4.6) min. The clinical benefit rates of 1 and 3 months after cryoablation were 100% and 91.7%, respectively. In addition,the complications after cryoablation were mild without severe ones such as cold shock, hepatic hemorrhage and renal insufficiency. Conclusion CT-guided argon-helium cryoablation for abdominal metastatic tumors is safe,effective and minimally invasive, with satisfying clinical benefit.
What problem does this paper attempt to address?